|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-1621-2024 - TRIDENTII HEMI CLUSTER44B- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-44B
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1622-2024 - TRIDENTII HEMI CLUSTER48D-indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-48D
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1623-2024 - TRIDENTII HEMI CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-50D
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1624-2024 - TRIDENTII HEMI CLUSTER52E-Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-52E
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1625-2024 - TRIDENTII HEMI CLUSTER54E- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-54E
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1626-2024 - TRIDENTII HEMI CLUSTER58F- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-58F
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1627-2024 - TRIDENTII HEMI CLUSTER66H- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 702-11-66H
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1628-2024 - TRIDENTII PSL CLUSTER48D- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 742-11-48D
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1629-2024 - TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 742-11-50D
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|
Z-1630-2024 - TRIDENTII PSL CLUSTER52E- Indicated for use in primary and revision patients at high risk of hip dislocation
Catalog Number: 742-11-52E
|
2
|
04/25/2024
|
Howmedica Osteonics Corp.
|